We are live on ! Find out more
Los Angeles Capital Management

Los Angeles Capital Management Portfolio holdings

AUM $25.4B
1-Year Est. Return 38.46%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$29.5B
AUM Growth
+$2.76B
Cap. Flow
+$238M
Cap. Flow %
0.81%
Top 10 Hldgs %
40.87%
Holding
1,571
New
251
Increased
436
Reduced
548
Closed
227

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$251M
2
AAPL icon
Apple
AAPL
+$168M
3
AMD icon
Advanced Micro Devices
AMD
+$152M
4
GILD icon
Gilead Sciences
GILD
+$139M
5
PLTR icon
Palantir
PLTR
+$137M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$362M
2
TSLA icon
Tesla
TSLA
+$233M
3
COST icon
Costco
COST
+$192M
4
WMT icon
Walmart Inc
WMT
+$167M
5
MA icon
Mastercard
MA
+$161M

Sector Composition

Rank Sector Weight
1 Technology 37.6%
2 Communication Services 12.78%
3 Healthcare 12.39%
4 Financials 10.47%
5 Industrials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERAS icon
1326
Erasca
ERAS
$6.45B
$76.5K ﹤0.01%
35,075
LXEO icon
1327
Lexeo Therapeutics
LXEO
$382M
$73.5K ﹤0.01%
+11,075
New +$53.6K
AMC icon
1328
AMC Entertainment Holdings
AMC
$2.26B
$73.2K ﹤0.01%
25,228
OLPX
1329
DELISTED
Olaplex Holdings
OLPX
$70.5K ﹤0.01%
53,810
CNDT icon
1330
Conduent
CNDT
$241M
$69.7K ﹤0.01%
24,905
TARA icon
1331
Protara Therapeutics
TARA
$219M
$67.6K ﹤0.01%
15,545
BHR
1332
Braemar Hotels & Resorts
BHR
$139M
$66.3K ﹤0.01%
24,285
EB
1333
DELISTED
Eventbrite
EB
$65.2K ﹤0.01%
25,855
-7,235
-22% -$18.9K
KLTR icon
1334
Kaltura
KLTR
$241M
$60.4K ﹤0.01%
41,975
MRDN
1335
Meridian Holdings Inc
MRDN
$178M
$60.4K ﹤0.01%
+4,455
New +$73K
CATX icon
1336
Perspective Therapeutics
CATX
$372M
$60.4K ﹤0.01%
17,595
MNTK icon
1337
Montauk Renewables
MNTK
$265M
$58.7K ﹤0.01%
29,205
IOVA icon
1338
Iovance Biotherapeutics
IOVA
$3.05B
$54K ﹤0.01%
24,871
-12,784
-34% -$30.2K
UIS icon
1339
Unisys
UIS
$206M
$45.8K ﹤0.01%
11,745
ALLO icon
1340
Allogene Therapeutics
ALLO
$714M
$44.6K ﹤0.01%
35,970
ATYR
1341
aTyr Pharma
ATYR
$53M
$33.1K ﹤0.01%
+45,830
New +$208K
SIEB icon
1342
Siebert Financial
SIEB
$70.8M
$31.4K ﹤0.01%
10,760
AAOI icon
1343
Applied Optoelectronics
AAOI
$11.7B
-33,135
Closed -$851K
ABUS icon
1344
Arbutus Biopharma
ABUS
$907M
-19,655
Closed -$60.7K
ACMR icon
1345
ACM Research
ACMR
$5.66B
-34,290
Closed -$888K
ACNT icon
1346
Ascent Industries
ACNT
$133M
-10,625
Closed -$134K
ACTG icon
1347
Acacia Research
ACTG
$455M
-51,155
Closed -$183K
ADUS icon
1348
Addus HomeCare
ADUS
$2.2B
-8,191
Closed -$944K
AEE icon
1349
Ameren
AEE
$30.1B
-2,214
Closed -$213K
AGL icon
1350
Agilon Health
AGL
$1.45B
-649
Closed -$37.3K

Similar funds

Los Angeles Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Los Angeles Capital Management held 1,571 positions worth $29.5B, up 10% from $26.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Los Angeles Capital Management's Q3 2025 filing shows 251 new, 436 increased, 548 reduced and 227 closed positions. Its largest new stake was eBay: 1,249,162 shares worth $114M. The largest sale was Visa, an estimated $362M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Communication Services and Healthcare.

  • Los Angeles Capital Management's largest Q3 2025 buy was eBay: 1,249,162 shares worth $114M.
  • Los Angeles Capital Management added most to NVIDIA in Q3 2025, an estimated $251M increase.
  • Los Angeles Capital Management's biggest Q3 2025 reduction was Visa, cutting an estimated $362M.
  • Los Angeles Capital Management fully exited VeriSign in Q3 2025, selling an estimated $20.2M.
  • Los Angeles Capital Management's ten largest holdings make up 41% of its $29.5B portfolio in Q3 2025.
  • Los Angeles Capital Management opened 251 new positions and closed 227 in Q3 2025.
  • Los Angeles Capital Management's portfolio value rose 10% quarter-over-quarter to $29.5B.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.